Patents by Inventor John Joseph Kopchick

John Joseph Kopchick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7309572
    Abstract: Growth homone-regulatable liver genes and proteins are described. These may be used as diagnostic markers of liver pathology.
    Type: Grant
    Filed: January 11, 2005
    Date of Patent: December 18, 2007
    Assignee: Ohio University
    Inventors: John Joseph Kopchick, Jean Tiong
  • Patent number: 7060437
    Abstract: Growth hormone-regulatable brown adipose tissue genes and proteins have been identified. They may be used as diagnostic markers of pathologies of adipose tissue.
    Type: Grant
    Filed: May 5, 2000
    Date of Patent: June 13, 2006
    Assignee: Ohio University
    Inventor: John Joseph Kopchick
  • Patent number: 6858389
    Abstract: Growth homone-regulatable liver genes and proteins are described. These may be used as diagnostic markers of liver pathology.
    Type: Grant
    Filed: May 5, 2000
    Date of Patent: February 22, 2005
    Assignee: Ohio University
    Inventors: John Joseph Kopchick, Jean Tiong
  • Publication number: 20030159164
    Abstract: The invention generally relates to synthesis of essential fatty acids and their derivatives, long-chain polyunsaturated fatty acids (LC-PUFAs) and eicosanoids in transfected cells and in transgenic animals.
    Type: Application
    Filed: October 23, 2002
    Publication date: August 21, 2003
    Inventors: John Joseph Kopchick, Bruce Kelder, Yung-Sheng Huang, Stephen J. Kirchner, Pradip Mukerji
  • Patent number: 5892070
    Abstract: The invention relates to transgenic non-human mammals characterized in that the genome of said mammals contain at least one heterologous gene encoding for the production of heterologous catalytic entity selected from the group consisting of enzymes and antibodies, and wherein said catalytic entity produces a second heterologous product in the milk of said mammal. Especially useful in the practice of the invention are human glycosyltransferases and transgenic sheep, goats and cows. The heterologous product includes oligosaccharides and glycoconjugates. Specifically exemplified, is the production of 2'-fucosyl-lactose in the milk of transgenic mice which contain and express a transgene encoding .alpha.-1,2-fucosyltransferase operatively linked to a mammary gland specific promoter.
    Type: Grant
    Filed: September 10, 1996
    Date of Patent: April 6, 1999
    Assignee: Abbott Laboratories
    Inventors: Pedro Antonio Prieto, David Fletcher Smith, Richard Dale Cummings, John Joseph Kopchick, Pradip Mukerji, Kelley Wilson Moremen, James Michael Pierce
  • Patent number: 5891698
    Abstract: The invention relates to humanized milk. The milk is produced by a non-human transgenic mammal wherein the genome of said transgenic non-human mammal contains at least one heterologous gene encoding for a human catalytic entity and wherein the catalytic entity produces oligosaccharides and glycoconjugates that are present in the milk of said transgenic non-human mammal. An especially useful catalytic entity is human glycosyltransferases which produce oligosaccharides and glyconjugates. Specifically exemplified, is the production of 2'-fucosyl-lactose in the milk of transgenic mice which contain and express a transgene encoding .alpha.-1,2-fucosyltransferase operatively linked to a mammary gland specific promoter. A method of obtaining humanized milk is disclosed.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: April 6, 1999
    Assignee: Abbott Laboratories
    Inventors: Pedro Antonio Prieto, David Fletcher Smith, Richard Dale Cummings, John Joseph Kopchick, Pradip Mukerji, Kelley Wilson Moremen, James Michael Pierce
  • Patent number: 5750176
    Abstract: The invention relates to the milk of a transgenic non-human mammal. The milk is characterized in that it contains heterologous components produced as the secondary gene products of a heterologous gene contained in the genome of the transgenic non-human mammal. The heterologous gene encodes a heterologous catalytic entity such as a human enzyme selected from the group consisting of glycosyltransferases, phosphorylases, hydroxylases, peptidases and sulfotransferases. Especially useful in the practice of the invention are human glycosyltransferases. The desired heterologous components include oligosaccahrides, glycoconjugates. Specifically exemplified, is the production of 2'-fucosyl-lactose in the milk of transgenic mice which contain and express a transgene encoding .alpha.-1,2-fucosyltransferase operatively linked to a mammary gland specific promoter.
    Type: Grant
    Filed: March 9, 1994
    Date of Patent: May 12, 1998
    Assignee: Abbott Laboratories
    Inventors: Pedro Antonio Prieto, David Fletcher Smith, Richard Dale Cummings, John Joseph Kopchick, Pradip Mukerji, Kelley Wilson Moremen, James Michael Pierce
  • Patent number: 5700671
    Abstract: The invention relates to transgenic non-human mammals characterized in that the genome of said mammals contain at least one heterologous gene encoding for the production of heterologous catalytic entity selected from the group consisting of enzymes and antibodies, and wherein said catalytic entity produces a second heterologous product in the milk of said mammal. Especially useful in the practice of the invention are human glycosyltransferases and transgenic sheep, goats and cows. The heterologous product includes oligosaccharides and glycoconjugates.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: December 23, 1997
    Assignee: Abbott Laboratories
    Inventors: Pedro Antonio Prieto, David Fletcher Smith, Richard Dale Cummings, John Joseph Kopchick, Pradip Mukerji, Kelley Wilson Moremen, James Michael Pierce